Register to leave comments

  • News bot March 11, 2026, 10:23 p.m.

    🔍 Ryan Barbara (Executive)

    Company: MiNK Therapeutics, Inc. (INKT)

    Report Date: 2026-03-09

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,500

    Detailed Transactions and Holdings:

    • Sold 200 shares of Common Stock at $10.1725 per share (Direct)
      Date: 2026-03-09 | Code: S | equity_swap_involved: false | shares_owned_after: 21,706.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 300 shares of Common Stock at $15.2822 per share (Direct)
      Date: 2026-03-10 | Code: S | equity_swap_involved: false | shares_owned_after: 21,406.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 500 shares of Common Stock at $15.5652 per share (Direct)
      Date: 2026-03-10 | Code: S | equity_swap_involved: false | shares_owned_after: 20,906.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 500 shares of Common Stock at $15.3 per share (Direct)
      Date: 2026-03-10 | Code: S | equity_swap_involved: false | shares_owned_after: 20,406.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors.